伸展負荷による血管平滑筋細胞死でのオートファジーの役割解明と動脈解離予防薬の開発

• Project/Area Number: 25K02429
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 47060:Clinical pharmacy-related
• Research Institution: Nara Medical University
• Principal Investigator: 吉栖 正典 奈良県立医科大学, 医学部, 教授 (60294667)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000); Fiscal Year 2026: ¥7,670,000 (Direct Cost: ¥5,900,000、Indirect Cost: ¥1,770,000); Fiscal Year 2025: ¥8,190,000 (Direct Cost: ¥6,300,000、Indirect Cost: ¥1,890,000)